(Q976559)

DrugBank

17 November 2015

Sparfloxacin.svg
512 × 322; 6 KB

0 references

mass

392.165997 dalton

1 reference

sparfloxacin (English)

4 October 2016

chemical formula

C₁₉H₂₂F₂N₄O₃

1 reference

sparfloxacin (English)

19 November 2016

canonical SMILES

CC1CN(CC(N1)C)C2=C(C3=C(C(=C2F)N)C(=O)C(=CN3C4CC4)C(=O)O)F

1 reference

sparfloxacin (English)

19 November 2016

isomeric SMILES

C[C@@H]1CN(C[C@@H](N1)C)C2=C(C3=C(C(=C2F)N)C(=O)C(=CN3C4CC4)C(=O)O)F

1 reference

sparfloxacin (English)

https://www.whocc.no/atc_ddd_index/?code=J01MA09

19 November 2016

defined daily dose

0.2 gram

route of administration

oral administration

1 reference

reference URL

medical condition treated

Escherichia coli infectious disease

1 reference

13 December 2016

1 reference

upper respiratory tract infection

13 December 2016

1 reference

13 December 2016

1 reference

gram-negative bacterial infection

13 December 2016

1 reference

13 December 2016

staphylococcal infection

1 reference

Food and Drug Administration

13 December 2016

18 December 1996

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/Q90AGA787L

2 November 2018

reference URL

http://www.rxlist.com/zagam-drug/indications-dosage.htm

significant drug interaction

pentamidine

1 reference

High-priority drug–drug interactions for use in electronic health records

amiodarone

1 reference

High-priority drug–drug interactions for use in electronic health records

anagrelide

1 reference

High-priority drug–drug interactions for use in electronic health records

arsenic trioxide

1 reference

High-priority drug–drug interactions for use in electronic health records

astemizole

1 reference

High-priority drug–drug interactions for use in electronic health records

azithromycin

1 reference

High-priority drug–drug interactions for use in electronic health records

bepridil

1 reference

High-priority drug–drug interactions for use in electronic health records

chloroquine

1 reference

High-priority drug–drug interactions for use in electronic health records

chlorpromazine

1 reference

High-priority drug–drug interactions for use in electronic health records

cisapride

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-citalopram

1 reference

High-priority drug–drug interactions for use in electronic health records

clarithromycin

1 reference

High-priority drug–drug interactions for use in electronic health records

cocaine

1 reference

High-priority drug–drug interactions for use in electronic health records

disopyramide

1 reference

High-priority drug–drug interactions for use in electronic health records

dofetilide

1 reference

High-priority drug–drug interactions for use in electronic health records

domperidone

1 reference

High-priority drug–drug interactions for use in electronic health records

dronedarone

1 reference

High-priority drug–drug interactions for use in electronic health records

droperidol

1 reference

High-priority drug–drug interactions for use in electronic health records

escitalopram

1 reference

High-priority drug–drug interactions for use in electronic health records

flecainide

1 reference

High-priority drug–drug interactions for use in electronic health records

halofantrine

1 reference

High-priority drug–drug interactions for use in electronic health records

haloperidol

1 reference

High-priority drug–drug interactions for use in electronic health records

ibutilide

1 reference

High-priority drug–drug interactions for use in electronic health records

mesoridazine

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-methadone

1 reference

High-priority drug–drug interactions for use in electronic health records

reference URL

https://www.drugs.com/drug-interactions/methadone-index.html

moxifloxacin

1 reference

High-priority drug–drug interactions for use in electronic health records

ondansetron

1 reference

High-priority drug–drug interactions for use in electronic health records

pimozide

1 reference

High-priority drug–drug interactions for use in electronic health records

probucol

1 reference

High-priority drug–drug interactions for use in electronic health records

procainamide

1 reference

High-priority drug–drug interactions for use in electronic health records

quinidine

1 reference

High-priority drug–drug interactions for use in electronic health records

sevoflurane

1 reference

High-priority drug–drug interactions for use in electronic health records

sotalol

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-sulpiride

1 reference

High-priority drug–drug interactions for use in electronic health records

terfenadine

1 reference

High-priority drug–drug interactions for use in electronic health records

thioridazine

1 reference

High-priority drug–drug interactions for use in electronic health records

pregnancy category

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

subject has role

topoisomerase inhibitor

1 reference

5 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

C061363

topoisomerase II inhibitor

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

C061363

‎WHO Aware Classification

15 March 2018

watch

1 reference

2023 ‎AWaRe classification‎

0 references

0 references

Sparfloxacin

0 references

Identifiers

InChI

InChI=1S/C19H22F2N4O3/c1-8-5-24(6-9(2)23-8)17-13(20)15(22)12-16(14(17)21)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6,22H2,1-2H3,(H,27,28)/t8-,9+

1 reference

sparfloxacin (English)

19 November 2016

2 references

sparfloxacin (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

110871-86-8

2 references

sparfloxacin (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=110871-86-8

8 April 2021

1 reference

Sparfloxacin (English)

19 November 2016

2 references

sparfloxacin (English)

19 November 2016

6956367

1 reference

Reaxys registry number

3658018

1 reference

sparfloxacin (English)

4 October 2016

ChEBI ID

9212

mapping relation type

2 references

SPARFLOXACIN (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C19H22F2N4O3/c1-8-5-24(6-9(2)23-8)17-13(20)15(22)12-16(14(17)21)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6,22H2,1-2H3,(H,27,28)/t8-,9+

1 reference

SPARFLOXACIN (English)

19 November 2016

2 references

inferred from InChIKey

splash10-000j-0922000000-9b26b987caa87b8a13af

1 reference

0 references

splash10-0007-0098000000-b03088bdb64f116827ad

0 references

splash10-052b-0009000000-d679c676e007f977b21f

0 references

DSSTox substance ID

DTXSID9023590

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.157.238

27 December 2018

ECHA Substance Infocard ID

5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (English)

quotation

CAS no.: 110871-86-8 (English)

100.157.238

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.157.238

27 December 2018

5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (English)

quotation

CAS no.: 110871-86-8 (English)

1 reference

Guide to Pharmacology Ligand ID

Sparfloxacin (English)

publication date

17 November 2015

10860

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

5 February 2021

1 reference

Medical Subject Headings

14 March 2018

1 reference

sparfloxacin (English)

19 November 2016

DrugBank ID

DB01208

1 reference

Human Metabolome Database ID

HMDB0015339

2 references

based on heuristic

inferred from InChIKey

2 references

sparfloxacin (English)

19 November 2016

NDF-RT ID

N0000148455

1 reference

sparfloxacin (English)

19 November 2016

0 references

1 reference

1 reference

sparfloxacin (English)

4 October 2016

1 reference

Immune Epitope Database and Analysis Resource

sparfloxacin (English)

4 October 2016

1 reference

1 March 2022

1 reference

6 April 2020

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

UMLS CUI

C0052585

1 reference

sparfloxacin (English)